[Overall survival and survival without local recurrence in case of radiotherapy of the tumor bed of ductal carcinomas in situ of the breast: review of the literature.]
Fiche publication
Date publication
janvier 2021
Journal
Gynecologie, obstetrique, fertilite & senologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Pr MATHELIN Carole, Pr NOEL Georges, Pr PIVOT Xavier
Tous les auteurs :
Kuntz L, Fèvre CL, Hild C, Keller A, Gharbi M, Mathelin C, Pivot X, Noël G, Antoni D
Lien Pubmed
Résumé
Carcinomas in situ represent more than 15 to 20% of breast cancers. Radiotherapy of whole breast is part of the therapeutic standard and follows surgery. However, the indication of tumor bed irradiation is still controversial and heterogeneous according to international practice even though it is a very frequent clinical situation. The aim of this study is to define the indications of tumor bed irradiation in the context of ductal carcinomas in situ and to discuss accelerated partial irradiation of the breast.
Mots clés
Boost, Breast cancer, Cancer du sein, Cancer in situ, Irradiation partielle accélérée, Radiothérapie, accelerated partial breast irradiation, boost, in situ, radiotherapy
Référence
Gynecol Obstet Fertil Senol. 2021 Jan 2;: